Scientists at the University of California, Davis have been able to grow vascularized human neural organoids by taking brain membrane cells from patients—and then coaxed some of them into stem cells.

Researchers from the Inspired Nanomaterials and Tissue Engineering Laboratory have developed an injectable bandage made of a hydrogel agent, according to a study published in the February 2018 edition of Acta Biomaterialia.

GE Healthcare has announced it will sell its revenue cycle, ambulatory care and workforce management software units to private equity firm Veritas Capital for $1.05 billion, following earlier plans for General Electric to sell assets and rumors the entire company could be broken up.

A bundled payment arrangement created in Texas by a non-profit Medicaid health maintenance organization (HMO) didn’t result in consistent savings for the two large physician groups participating, according to research displayed at the American College of Healthcare Executives (ACHE) Congress in Chicago.

A recent small-sample survey published online March 22 in Genetics in Medicine found direct-to-consumer DNA tests may produce false-positives in 40 percent of variants when subjected to clinical confirmation testing.

Pressure from lower-priced healthcare options has already been hitting hospitals’ bottom lines. If Walmart’s early talks to acquire Humana come to fruition, that pressure would only intensify, according to the Wall Street Journal.

Non-clinical factors such as communication, personality and interactions with staff may be the keys to a high physician rating, according to a report that included almost seven million patient reviews and comments.

Blockchain has been touted—to the point of being called overhyped—as the technological breakthrough healthcare organizations need to more easily secure and store patient data. Five companies are now launching a pilot program to see if blockchain can live up to its promises by applying the technology to the common problem of inaccurate provider directories.